Aerpio Pharmaceuticals: Is This Stock A Buy Or Sell? Not Until The Merger Is Over
Summary: Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company that is developing compounds that activate Tie2 for...
Month: July 2021
IPO Day With Absci CEO Sean McClain – The Google Of Synthetic Biology (Video)
Summary: Absci, a synthetic biology company whose platform technology aids in the drug discovery process, is going public...
AbSci Proposes Terms For $200 Million IPO
Summary: AbSci has filed to raise $200 million in a U.S. IPO.The firm is commercializing a biologic development...
To Their Disadvantage, Meme Traders Rescue Institutions Holding Exela’s Debt
Summary: XELA is heavily indebted, with $1.5 billion maturing in the next 24 months.Most revenues come from low-margin,...
Affimed: Remaining Bullish Despite Study Discontinuation
Summary: Affimed recently reported their Q1 earnings that revealed a solid beat on EPS and revenue. However, the company...
Hycroft Mining Has A Lot Of Gold But There Are Many Red Flags
Summary: The company’s flagship project has reserves of 11.9 million ounces of gold and 478.5 million ounces of...